The olive leaf nootropic blend ingredients market is valued at USD 580 million in 2026 and is projected to reach USD 1,910 million by 2036, growing at a CAGR of 12.9%. By ingredient type, olive leaf polyphenol extracts hold a 39% share, while dietary supplements account for 47% of the application segment.